Table of Contents
Highlights
MCT Focus: Developmental Therapeutics in Radiation Oncology
- MCT Focus: Developmental Therapeutics in Radiation OncologyJohn S. LazoMol Cancer Ther February 1 2018 17 (2) 332-335; DOI:10.1158/1535-7163.MCT-17-1244
- MCT Focus: Developmental Therapeutics in Radiation OncologyKamalakannan Palanichamy, Disha Patel, John R. Jacob, Kevin T. Litzenberg, Nicolaus Gordon, Kirstin Acus, Shin-ei Noda and Arnab ChakravartiMol Cancer Ther February 1 2018 17 (2) 336-346; DOI:10.1158/1535-7163.MCT-17-0429
- MCT Focus: Developmental Therapeutics in Radiation OncologyRavi S. Narayan, Ana Gasol, Paul L.G. Slangen, Fleur M.G. Cornelissen, Tonny Lagerweij, Hou Y.Y.E. Veldman, Rogier Dik, Jaap van den Berg, Ben J. Slotman, Tom Würdinger, Daphne A. Haas-Kogan, Lukas J.A. Stalpers, Brigitta G. Baumert, Bart A. Westerman, Jan Theys and Peter SminiaMol Cancer Ther February 1 2018 17 (2) 347-354; DOI:10.1158/1535-7163.MCT-17-0480
- MCT Focus: Developmental Therapeutics in Radiation OncologyIris Eke, Adeola Y. Makinde, Molykutty J. Aryankalayil, Veit Sandfort, Sanjeewani T. Palayoor, Barbara H. Rath, Lance Liotta, Mariaelena Pierobon, Emanuel F. Petricoin, Matthew F. Brown, Jayne M. Stommel, Mansoor M. Ahmed and C. Norman ColemanMol Cancer Ther February 1 2018 17 (2) 355-367; DOI:10.1158/1535-7163.MCT-17-0262
- MCT Focus: Developmental Therapeutics in Radiation Oncology | AuthorChoiceVanessa Vanderdys, Amir Allak, Fadila Guessous, Mouadh Benamar, Paul W. Read, Mark J. Jameson and Tarek AbbasMol Cancer Ther February 1 2018 17 (2) 368-380; DOI:10.1158/1535-7163.MCT-17-0083
- MCT Focus: Developmental Therapeutics in Radiation OncologyBlaz Groselj, Jia-Ling Ruan, Helen Scott, Jessica Gorrill, Judith Nicholson, Jacqueline Kelly, Selvakumar Anbalagan, James Thompson, Michael R.L. Stratford, Sarah J. Jevons, Ester M. Hammond, Cheryl L. Scudamore, Martin Kerr and Anne E. KiltieMol Cancer Ther February 1 2018 17 (2) 381-392; DOI:10.1158/1535-7163.MCT-17-0011
- MCT Focus: Developmental Therapeutics in Radiation OncologyC. Noreen Hinrichs, Mirjam Ingargiola, Theresa Käubler, Steffen Löck, Achim Temme, Alvaro Köhn-Luque, Andreas Deutsch, Olena Vovk, Oleh Stasyk and Leoni A. Kunz-SchughartMol Cancer Ther February 1 2018 17 (2) 393-406; DOI:10.1158/1535-7163.MCT-16-0807
- MCT Focus: Developmental Therapeutics in Radiation OncologyElena V. Efimova, Natalia Ricco, Edwardine Labay, Helena J. Mauceri, Amy C. Flor, Aishwarya Ramamurthy, Harold G. Sutton, Ralph R. Weichselbaum and Stephen J. KronMol Cancer Ther February 1 2018 17 (2) 407-418; DOI:10.1158/1535-7163.MCT-17-0288
- MCT Focus: Developmental Therapeutics in Radiation OncologyJie Du, Jun Shang, Fei Chen, Yushuo Zhang, Narui Yin, Ting Xie, Haowen Zhang, Jiahua Yu and Fenju LiuMol Cancer Ther February 1 2018 17 (2) 419-431; DOI:10.1158/1535-7163.MCT-17-0090
- MCT Focus: Developmental Therapeutics in Radiation OncologyAkinori Morita, Ippei Takahashi, Megumi Sasatani, Shin Aoki, Bing Wang, Shinya Ariyasu, Kaoru Tanaka, Tetsuji Yamaguchi, Akiko Sawa, Yurie Nishi, Tatsuro Teraoka, Shohei Ujita, Yosuke Kawate, Chihiro Yanagawa, Keiji Tanimoto, Atsushi Enomoto, Mitsuru Nenoi, Kenji Kamiya, Yasushi Nagata, Yoshio Hosoi and Toshiya InabaMol Cancer Ther February 1 2018 17 (2) 432-442; DOI:10.1158/1535-7163.MCT-16-0554
Small Molecule Therapeutics
- Small Molecule Therapeutics | AuthorChoiceShumei Song, Min Xie, Ailing W. Scott, Jiankang Jin, Lang Ma, Xiaochuan Dong, Heath D. Skinner, Randy L. Johnson, Sheng Ding and Jaffer A. AjaniMol Cancer Ther February 1 2018 17 (2) 443-454; DOI:10.1158/1535-7163.MCT-17-0560
- Small Molecule TherapeuticsKristen M. Smith, Patrick C. Fagan, Elena Pomari, Giuseppe Germano, Chiara Frasson, Colin Walsh, Ian Silverman, Paolo Bonvini and Gang LiMol Cancer Ther February 1 2018 17 (2) 455-463; DOI:10.1158/1535-7163.MCT-17-0419
- Small Molecule TherapeuticsYan Huang, Wei Hu, Jie Huang, Fangrong Shen, Yunjie Sun, Cristina Ivan, Sunila Pradeep, Robert Dood, Monika Haemmerle, Dahai Jiang, Lingegowda S. Mangala, Kyunghee Noh, Jean M. Hansen, Heather J. Dalton, Rebecca A. Previs, Archana S. Nagaraja, Michael McGuire, Nicholas B. Jennings, Russell Broaddus, Robert L. Coleman and Anil K. SoodMol Cancer Ther February 1 2018 17 (2) 464-473; DOI:10.1158/1535-7163.MCT-17-0006
- Small Molecule TherapeuticsFuli Wang, Hongyong Zhang, Ai-Hong Ma, Weimin Yu, Maike Zimmermann, Jun Yang, Sung Hee Hwang, Daniel Zhu, Tzu-yin Lin, Michael Malfatti, Kenneth W. Turteltaub, Paul T. Henderson, Susan Airhart, Bruce D. Hammock, Jianlin Yuan, Ralph W. de Vere White and Chong-Xian PanMol Cancer Ther February 1 2018 17 (2) 474-483; DOI:10.1158/1535-7163.MCT-16-0818
- Small Molecule TherapeuticsSudjit Luanpitpong, Nawin Chanthra, Montira Janan, Jirarat Poohadsuan, Parinya Samart, Yaowalak U-Pratya, Yon Rojanasakul and Surapol IssaragrisilMol Cancer Ther February 1 2018 17 (2) 484-496; DOI:10.1158/1535-7163.MCT-17-0390
- Small Molecule TherapeuticsLubing Gu, Hailong Zhang, Tao Liu, Alexander Draganov, Sha Yi, Binghe Wang and Muxiang ZhouMol Cancer Ther February 1 2018 17 (2) 497-507; DOI:10.1158/1535-7163.MCT-17-0566
- Small Molecule TherapeuticsHuang-Chiao Huang, Joyce Liu, Yan Baglo, Imran Rizvi, Sriram Anbil, Michael Pigula and Tayyaba HasanMol Cancer Ther February 1 2018 17 (2) 508-520; DOI:10.1158/1535-7163.MCT-17-0568
Cancer Biology and Translational Studies
- Cancer Biology and Translational StudiesAtrish Bagchi, Jaafar N. Haidar, Scott W. Eastman, Michal Vieth, Michael Topper, Michelle D. Iacolina, Jason M. Walker, Amelie Forest, Yang Shen, Ruslan D. Novosiadly and Kathryn M. FergusonMol Cancer Ther February 1 2018 17 (2) 521-531; DOI:10.1158/1535-7163.MCT-17-0575
- Cancer Biology and Translational StudiesAgnès Figueras, Elisenda Alsina-Sanchís, Álvaro Lahiguera, Manuel Abreu, Laura Muinelo-Romay, Gema Moreno-Bueno, Oriol Casanovas, Mariona Graupera, Xavier Matias-Guiu, August Vidal, Alberto Villanueva and Francesc ViñalsMol Cancer Ther February 1 2018 17 (2) 532-543; DOI:10.1158/1535-7163.MCT-17-0643
Large Molecule Therapeutics
- Large Molecule Therapeutics | AuthorChoiceβ-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor ModelsShanthi Ganesh, Xue Shui, Kevin P. Craig, Martin L. Koser, Girish R. Chopda, Wendy A. Cyr, Chengjung Lai, Henryk Dudek, Weimin Wang, Bob D. Brown and Marc T. AbramsMol Cancer Ther February 1 2018 17 (2) 544-553; DOI:10.1158/1535-7163.MCT-17-0605
- Large Molecule Therapeutics | AuthorChoiceFu Li, May Kung Sutherland, Changpu Yu, Roland B. Walter, Lori Westendorf, John Valliere-Douglass, Lucy Pan, Ashley Cronkite, Django Sussman, Kerry Klussman, Michelle Ulrich, Martha E. Anderson, Ivan J. Stone, Weiping Zeng, Mechthild Jonas, Timothy S. Lewis, Maitrayee Goswami, Sa A. Wang, Peter D. Senter, Che-Leung Law, Eric J. Feldman and Dennis R. BenjaminMol Cancer Ther February 1 2018 17 (2) 554-564; DOI:10.1158/1535-7163.MCT-17-0742
- Large Molecule TherapeuticsRhonda C. Kines, Isabella Varsavsky, Sanghamitra Choudhary, Debaditya Bhattacharya, Sean Spring, Roger McLaughlin, Shin J. Kang, Hans E. Grossniklaus, Demetrios Vavvas, Stephen Monks, John R. MacDougall, Elisabet de los Pinos and John T. SchillerMol Cancer Ther February 1 2018 17 (2) 565-574; DOI:10.1158/1535-7163.MCT-17-0953
Models and Technologies
- Models and Technologies | AuthorChoiceY. K. Stella Man, James A. Davies, Lynda Coughlan, Constantia Pantelidou, Alfonso Blázquez-Moreno, John F. Marshall, Alan L. Parker and Gunnel HalldénMol Cancer Ther February 1 2018 17 (2) 575-587; DOI:10.1158/1535-7163.MCT-17-0671
February 2018
Volume 17, Issue 2
Volume 17, Issue 2
Issue Highlights
Jump to
Advertisement